Orgenesis (ORGS) Revenue & Revenue Breakdown

Orgenesis Revenue Highlights

Latest Revenue (Y)

$530.00K

Latest Revenue (Q)

$347.00K

Orgenesis Revenue by Period

Orgenesis Revenue by Year

Date	Revenue	Change
2023-12-31	$530.00K	-98.53%
2022-12-31	$36.02M	1.47%
2021-12-31	$35.50M	363.96%
2020-12-31	$7.65M	-76.99%
2019-12-31	$33.26M	78.27%
2018-11-30	$18.66M	84.90%
2017-11-30	$10.09M	57.71%
2016-11-30	$6.40M	115.10%
2015-11-30	$2.97M	100.00%
2014-11-30	-	100.00%
2013-11-30	-	100.00%
2012-11-30	-	100.00%
2011-11-30	-	100.00%
2010-11-30	-	100.00%
2009-11-30	-	100.00%
2008-11-30	-	-

Orgenesis generated $530.00K in revenue during NA 2023, up -98.53% compared to the previous quarter, and up 2.84% compared to the same period a year ago.

Orgenesis Revenue by Quarter

Date	Revenue	Change
2024-09-30	$347.00K	41.06%
2024-06-30	$246.00K	74.47%
2024-03-31	$141.00K	-101.04%
2023-12-31	$-13.60M	-12462.73%
2023-09-30	$110.00K	-98.42%
2023-06-30	$6.97M	-0.98%
2023-03-31	$7.04M	-48.30%
2022-12-31	$13.62M	70.56%
2022-09-30	$7.99M	10.93%
2022-06-30	$7.20M	-0.15%
2022-03-31	$7.21M	4.64%
2021-12-31	$6.89M	-20.56%
2021-09-30	$8.68M	-17.72%
2021-06-30	$10.54M	12.31%
2021-03-31	$9.39M	308.93%
2020-12-31	$2.30M	32.79%
2020-09-30	$1.73M	-1.14%
2020-06-30	$1.75M	-6.87%
2020-03-31	$1.88M	-79.31%
2019-12-31	$9.08M	-0.48%
2019-09-30	$9.12M	17.58%
2019-06-30	$7.76M	6.25%
2019-03-31	$7.30M	25.84%
2018-11-30	$5.80M	-6.87%
2018-08-31	$6.23M	56.26%
2018-05-31	$3.99M	51.25%
2017-12-31	$2.64M	-21.94%
2017-11-30	$3.38M	31.81%
2017-08-31	$2.56M	11.49%
2017-05-31	$2.30M	24.08%
2017-02-28	$1.85M	-2.32%
2016-11-30	$1.90M	2.54%
2016-08-31	$1.85M	63.34%
2016-05-31	$1.13M	-25.53%
2016-02-29	$1.52M	24.86%
2015-11-30	$1.22M	30.03%
2015-08-31	$936.22K	14.11%
2015-05-31	$820.42K	100.00%
2015-02-28	-	100.00%
2014-11-30	-	100.00%
2014-08-31	-	100.00%
2014-05-31	-	100.00%
2014-02-28	-	100.00%
2013-11-30	-	100.00%
2013-08-31	-	100.00%
2013-05-31	-	100.00%
2013-02-28	-	100.00%
2012-11-30	-	100.00%
2012-08-31	-	100.00%
2012-05-31	-	100.00%
2012-02-29	-	100.00%
2011-11-30	-	100.00%
2011-08-31	-	100.00%
2011-05-31	-	100.00%
2011-02-28	-	100.00%
2010-11-30	-	100.00%
2010-08-31	-	100.00%
2010-05-31	-	100.00%
2010-02-28	-	100.00%
2009-11-30	-	100.00%
2009-08-31	-	100.00%
2009-05-31	-	100.00%
2009-02-28	-	-

Orgenesis generated $347.00K in revenue during Q3 2024, up 41.06% compared to the previous quarter, and up 4.97% compared to the same period a year ago.

Orgenesis Revenue Breakdown

Orgenesis Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Eliminations	$-4.42M	$-5.58M	-	-	-
Consolidated	-	$1.28M	-	-	-
Cell Process Development Services	-	-	$2.68M	$1.58M	-
POC and Hospital Services	-	-	$32.82M	$6.07M	-
Cell manufacturing services	-	-	-	-	$4.82M
Poc Development Services	-	-	-	-	$3.11M
Cell process development services	-	-	-	-	$19.93M
Tech transfer services	-	-	-	-	$5.40M

Orgenesis's latest annual revenue breakdown by segment (product or service), as of Dec 23: Eliminations (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Mar 23	Dec 21	Dec 20	Dec 19	Sep 19	Jun 19	Mar 19	Nov 18
Cell Process Development Services And Hospital Services	$347.00K	$141.00K	-	-	-	-	-	-	-	-	-	-
Eliminations	-	-	-	$-1.87M	-	-	-	-	-	-	-	-
Consolidated	-	-	-	-	$7.04M	-	-	-	-	-	-	-
POC and Hospital Services	-	-	-	-	-	$6.58M	$1.78M	-	-	-	-	-
Cell Process Development Services	-	-	-	-	-	$317.00K	$519.00K	-	-	-	-	-
Cell process development services	-	-	-	-	-	-	-	$7.94M	$2.75M	$4.06M	$5.17M	-
Cell manufacturing services	-	-	-	-	-	-	-	-	$3.49M	$1.03M	$296.00K	-
Tech transfer services	-	-	-	-	-	-	-	-	$1.86M	$1.70M	$1.83M	-
Poc Services	-	-	-	-	-	-	-	-	$1.01M	$962.00K	-	-
Revenue from grants	-	-	-	-	-	-	-	-	-	-	-	$440.00K

Orgenesis's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Cell Process Development Services And Hospital Services (100.00%).

Orgenesis Revenue Breakdown by Country

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Jun 23
UNITED STATES	$265.00K	$75.00K	$2.57M

Orgenesis's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (100.00%).

Orgenesis Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TNGX	Tango Therapeutics	$36.53M	$11.61M
ADAG	Adagene	$18.11M	$833.34K
TFFP	TFF Pharmaceuticals	$733.87K	$193.39K
DSGN	Design Therapeutics	-	-
RZLT	Rezolute	-	-
ANTX	AN2 Therapeutics	-	-
LIXT	Lixte Biotechnology	-	-
AVTE	Aerovate Therapeutics	-	-
ACRV	Acrivon Therapeutics	-	-
ACHL	Achilles Therapeutics	-	-
INDP	Indaptus Therapeutics	-	-
QNRX	Quoin Pharmaceuticals	-	-
KTTA	Pasithea Therapeutics	-	-

ORGS Revenue FAQ

What is Orgenesis’s yearly revenue?

Orgenesis's yearly revenue for 2023 was $530K, representing a decrease of -98.53% compared to 2022. The company's yearly revenue for 2022 was $36.02M, representing an increase of 1.47% compared to 2021. ORGS's yearly revenue for 2021 was $35.5M, representing an increase of 363.96% compared to 2020.

What is Orgenesis’s quarterly revenue?

Orgenesis's quarterly revenue for Q3 2024 was $347K, a 41.06% increase from the previous quarter (Q2 2024), and a 215.45% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $246K, a 74.47% increase from the previous quarter (Q1 2024), and a -96.47% decrease year-over-year (Q2 2023). ORGS's quarterly revenue for Q1 2024 was $141K, a -101.04% decrease from the previous quarter (Q4 2023), and a -98.00% decrease year-over-year (Q1 2023).

What is Orgenesis’s revenue growth rate?

Orgenesis's revenue growth rate for the last 3 years (2021-2023) was -98.51%, and for the last 5 years (2019-2023) was -98.41%.

What are Orgenesis’s revenue streams?

Orgenesis's revenue streams in c 23 are Eliminations